17.34
price up icon3.34%   0.56
after-market 시간 외 거래: 17.34
loading
전일 마감가:
$16.78
열려 있는:
$16.47
하루 거래량:
1.04M
Relative Volume:
0.60
시가총액:
$2.10B
수익:
$631.73M
순이익/손실:
$-239.78M
주가수익비율:
-9.0785
EPS:
-1.91
순현금흐름:
$-33.45M
1주 성능:
+9.82%
1개월 성능:
-13.39%
6개월 성능:
-36.90%
1년 성능:
-56.34%
1일 변동 폭
Value
$16.35
$17.36
1주일 범위
Value
$15.02
$17.36
52주 변동 폭
Value
$14.02
$57.90

10X 제노믹스 Stock (TXG) Company Profile

Name
명칭
10 X Genomics Inc
Name
전화
(925) 401-7300
Name
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
직원
1,259
Name
트위터
@10xgenomics
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
TXG's Discussions on Twitter

10X 제노믹스 Stock (TXG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-14 개시 Guggenheim Buy
2023-12-13 개시 Wolfe Research Outperform
2023-12-12 업그레이드 BofA Securities Underperform → Neutral
2023-07-05 재개 JP Morgan Overweight
2023-05-10 개시 Barclays Overweight
2023-03-31 개시 Stephens Overweight
2023-02-02 개시 UBS Neutral
2022-12-14 개시 Deutsche Bank Buy
2022-08-18 다운그레이드 Goldman Neutral → Sell
2022-07-25 개시 Canaccord Genuity Buy
2022-07-15 다운그레이드 BofA Securities Neutral → Underperform
2022-07-15 다운그레이드 William Blair Outperform → Mkt Perform
2021-10-15 재개 Cowen Outperform
2021-09-14 다운그레이드 BofA Securities Buy → Neutral
2021-03-15 개시 William Blair Outperform
2020-12-02 개시 Goldman Neutral
2020-09-09 개시 Morgan Stanley Overweight
2020-07-10 개시 Stifel Buy
2020-03-05 개시 Guggenheim Buy
2020-01-07 개시 Citigroup Buy
2019-10-07 개시 BofA/Merrill Buy
2019-10-07 개시 Cowen Outperform
2019-10-07 개시 JP Morgan Overweight
2019-09-24 개시 Evercore ISI Outperform
모두보기

10X 제노믹스 주식(TXG)의 최신 뉴스

pulisher
Nov 04, 2024

10x Genomics Inc (TXG) Trading 2.45% Higher on Nov 4 - GuruFocus.com

Nov 04, 2024
pulisher
Nov 01, 2024

10x Genomics (NASDAQ:TXG) Price Target Cut to $19.00 by Analysts at Barclays - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

FY2024 EPS Estimates for 10x Genomics Boosted by Analyst - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Allspring Global Investments Holdings LLC Has $880,000 Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - PR Newswire

Oct 31, 2024
pulisher
Oct 31, 2024

10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative – Company Announcement - Financial Times

Oct 31, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30 - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $20.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics: Q3 Earnings Snapshot - The Advocate

Oct 30, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics falls 7% on 2024 revenue guidance cut - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Inc Reports Q3 2024 Revenue of $151.7 Million, Missing Estimates; Gross Margin Improves to 70% - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook By Investing.com - Investing.com UK

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times

Oct 29, 2024
pulisher
Oct 29, 2024

Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance

Oct 29, 2024
pulisher
Oct 24, 2024

10X Genomics' SWOT analysis: stock faces headwinds amid strong consumables demand - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Lecap Asset Management Ltd. Purchases Shares of 38,829 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

10x Genomics (TXG) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Oct 23, 2024
pulisher
Oct 22, 2024

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program - StockTitan

Oct 22, 2024
pulisher
Oct 22, 2024

10x Genomics (TXG) Set to Announce Earnings on Tuesday - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Morgan Stanley spotlights 10 small-cap stocks with at least 50% upside - Kursiv Media

Oct 21, 2024
pulisher
Oct 19, 2024

10x Genomics Inc.: How Are They Adapting to Market Conditions & Customer Needs?Major Drivers - Smartkarma

Oct 19, 2024
pulisher
Oct 17, 2024

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Analysts Set 10x Genomics, Inc. (NASDAQ:TXG) Target Price at $30.60 - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

SG Americas Securities LLC Sells 77,766 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches - PR Newswire

Oct 15, 2024
pulisher
Oct 15, 2024

Barclays Lowers 10x Genomics (NASDAQ:TXG) Price Target to $21.00 - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

10x Genomics, Inc. to Post Q3 2024 Earnings of ($0.31) Per Share, Leerink Partnrs Forecasts (NASDAQ:TXG) - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

10x Genomics Stock: Deciphering The Preliminary Q3 Earnings (NASDAQ:TXG) - Seeking Alpha

Oct 12, 2024
pulisher
Oct 11, 2024

The Price Is Right For 10x Genomics, Inc. (NASDAQ:TXG) Even After Diving 28% - Simply Wall St

Oct 11, 2024
pulisher
Oct 11, 2024

10X Genomics stock hits 52-week low at $14.91 amid market shifts - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

10x Genomics reports dip in Q3 instrument sales, growth in consumables By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 10, 2024

These Stocks Are Moving the Most Today: Tesla, Super Micro, AMD, and More - Barron's

Oct 10, 2024
pulisher
Oct 10, 2024

10x Genomics reports dip in Q3 instrument sales, growth in consumables - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Where 10x Genomics Stands With Analysts - Benzinga

Oct 10, 2024
pulisher
Oct 10, 2024

10x Genomics' (TXG) Overweight Rating Reiterated at Stephens - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

10x Genomics (NASDAQ:TXG) PT Lowered to $20.00 - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

10x Genomics (NASDAQ:TXG) Reaches New 1-Year LowShould You Sell? - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

10X Genomics stock hits 52-week low at $14.91 amid market shifts By Investing.com - Investing.com South Africa

Oct 10, 2024
pulisher
Oct 10, 2024

Tesla, Delta, Super Micro, 10x Genomics, Domino’s, TD Bank, and More Stock Movers - Barron's

Oct 10, 2024
pulisher
Oct 10, 2024

Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead - Benzinga

Oct 10, 2024

10X 제노믹스 (TXG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

10X 제노믹스 주식 (TXG) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hindson Benjamin J.
See Remarks
Aug 22 '24
Sale
22.53
4,351
98,027
345,704
McAnear Justin J.
Former Chief Financial Officer
Aug 22 '24
Sale
22.53
2,961
66,710
143,242
$49.80
price up icon 2.66%
health_information_services EVH
$23.57
price up icon 0.90%
$17.63
price up icon 4.88%
health_information_services WAY
$29.01
price up icon 1.26%
health_information_services RCM
$14.27
price down icon 0.07%
health_information_services TEM
$44.50
price down icon 10.10%
자본화:     |  볼륨(24시간):